D. E. Shaw & Co., Inc. ACHILLION PHARMACEUTICALS IN Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
N/A
-125,527 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
N/A
-440,992 Reduced 77.84%
125,527 $757,000
Q3 2019

Nov 14, 2019
SELL
N/A
-548,518 Reduced 49.19%
566,519 $2.04 Million
Q2 2019

Aug 14, 2019
BUY
N/A
218,241 Added 24.34%
1,115,037 $2.99 Million
Q1 2019

May 15, 2019
BUY
N/A
441,973 Added 97.17%
896,796 $2.66 Million
Q4 2018

Feb 14, 2019
BUY
N/A
320,949 Added 239.74%
454,823 $723,000
Q3 2018

Nov 14, 2018
SELL
N/A
-180,133 Reduced 57.37%
133,874 $493,000
Q2 2018

Aug 14, 2018
SELL
N/A
-23,779 Reduced 7.04%
314,007 $889,000
Q1 2018

May 15, 2018
SELL
N/A
-29,411 Reduced 8.01%
337,786 $1.25 Million
Q4 2017

Feb 14, 2018
BUY
N/A
346,870 Added 1706.45%
367,197 $1.06 Million
Q3 2017

Nov 14, 2017
BUY
N/A
20,327
20,327 $91,000
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email